Standout Papers

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor 1998 2026 2007 2016 588
  1. SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor (1998)
    M Rinaldi-Carmona, Francis Barth et al. Journal of Pharmacology and Experimental Therapeutics

Immediate Impact

6 by Nobel laureates 39 from Science/Nature 69 standout
Sub-graph 1 of 21

Citing Papers

Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors
2025 StandoutNature
Ultra-large library docking for discovering new chemotypes
2019 StandoutNature
2 intermediate papers

Works of J. C. Brelière being referenced

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
1992

Author Peers

Author Last Decade Papers Cites
J. C. Brelière 1138 810 294 597 27 1.6k
James A. Palmer 746 576 445 651 34 1.8k
Richard Alonso 791 547 163 416 40 1.6k
Gordon S. Baxter 1090 937 348 257 27 2.0k
Florence Oury-Donat 972 841 417 822 25 2.0k
Stéphane Doly 865 610 331 225 43 1.6k
Eyassu Chernet 1063 625 226 298 28 1.9k
Antonio Luchicchi 875 529 223 495 35 1.6k
Laura J. Sim 1208 572 261 700 23 1.6k
Keith F. Martin 1024 552 229 305 53 1.8k
M. Kathmann 1085 833 256 1060 42 2.2k

All Works

Loading papers...

Rankless by CCL
2026